• 
  Antoine Brault, Isabelle Pontais, Vincent Enouf, Christine Debeuret, Emma Bloch, et al.. Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023–24: a modelling study. The Lancet Child & Adolescent Health, 2024, 8 (10), pp.721-729. ⟨10.1016/S2352-4642(24)00143-3⟩. ⟨pasteur-04501465v2⟩
• 
  Alexia Rivera, Josée Dussault, Damien Oudin Doglioni, Sandra Chyderiotis, Jonathan Sicsic, et al.. Sociodemographic determinants of HPV vaccine awareness, uptake, and intention among parents of adolescents in France 2021-22. Human Vaccines & Immunotherapeutics, 2024, 20 (1), pp.2381300. ⟨10.1080/21645515.2024.2381300⟩. ⟨hal-04747813⟩
• 
  Marianne Cerf, Anne-Juliette Serry, Lucile Marty, Sophie Nicklaus, Pauline Ducrot. Evidence on consumers’ perceptions, understanding and uses of the Nutri-Score to improve communication about its update: a qualitative study with shopping observations in France. BMC Public Health, 2024, 24 (1), pp.3037. ⟨10.1186/s12889-024-20092-w⟩. ⟨hal-04774311⟩
• 
  Pol Prévot-Monsacré, Florent Hamaide-Defrocourt, Ophélie Guyonvarch, Shirley Masse, Cécile Souty, et al.. What is the relevancy of a surveillance of mumps without a systematic laboratory confirmation in highly immunized populations? Epidemiology of suspected and biologically confirmed mumps cases seen in general practice in France between 2014 and 2020. Vaccine, 2024, 42 (5), pp.1065-1070. ⟨10.1016/j.vaccine.2023.12.017⟩. ⟨hal-04616694⟩
• 
  Stéphanie Raffestin, Ambre Tinard, Antoine Enfissi, Marie-Line Joffret, Timothée Lichtenstein, et al.. Detection of circulating type 3 vaccine-derived polioviruses in French Guiana, May to August 2024. Eurosurveillance, 2024, 29 (5), pp.2400705. ⟨10.2807/1560-7917.ES.2024.29.45.2400705⟩. ⟨hal-04772605⟩

1 100

872